LUMAXIND.BO(LUMAXIND.BO)
LUMAXIND.BO
No analyst ratings available
No analyst price targets available for LUMAXIND.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $49.75B | $58.08B | $67.30B |
| Low | $49.70B | $57.68B | $67.02B |
| High | $49.81B | $58.49B | $67.59B |
| EBITDA Avg | $5.69B | $6.64B | $7.70B |
| Low | $5.68B | $6.59B | $7.66B |
| High | $5.69B | $6.69B | $7.73B |
| EBIT Avg | $3.91B | $4.56B | $5.29B |
| Low | $3.91B | $4.53B | $5.27B |
| High | $3.91B | $4.60B | $5.31B |
| Net Income Avg | $2.27B | $3.03B | $3.78B |
| Low | $2.21B | $3.02B | $3.76B |
| High | $2.33B | $3.05B | $3.80B |
| EPS Avg | $242.75 | $324.45 | $403.95 |
| Low | $236.60 | $323.00 | $401.71 |
| High | $248.90 | $325.90 | $406.19 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $12.45B | $12.30B | $13.60B |
| Low | $12.45B | $12.30B | $13.60B |
| High | $12.45B | $12.30B | $13.60B |
| EBITDA Avg | $1.42B | $1.41B | $1.55B |
| Low | $1.42B | $1.41B | $1.55B |
| High | $1.42B | $1.41B | $1.55B |
| EBIT Avg | $978M | $967M | $1.07B |
| Low | $978M | $967M | $1.07B |
| High | $978M | $967M | $1.07B |
| Net Income Avg | $545M | $534M | $662M |
| Low | $545M | $534M | $662M |
| High | $545M | $534M | $662M |
| EPS Avg | $58.30 | $57.10 | $70.80 |
| Low | $58.30 | $57.10 | $70.80 |
| High | $58.30 | $57.10 | $70.80 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |